Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation

[11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [11C]PK11195, another TSPO radioligand. We measured the specific binding signals with [3H]PK11195 and...

Full description

Saved in:
Bibliographic Details
Published inJournal of cerebral blood flow and metabolism Vol. 30; no. 9; pp. 1608 - 1618
Main Authors Owen, David R, Howell, Owain W, Tang, Sac-Pham, Wells, Lisa A, Bennacef, Idriss, Bergstrom, Mats, Gunn, Roger N, Rabiner, Eugenii A, Wilkins, Martin R, Reynolds, Richard, Matthews, Paul M, Parker, Christine A
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.09.2010
Nature Publishing Group
Sage Publications Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [11C]PK11195, another TSPO radioligand. We measured the specific binding signals with [3H]PK11195 and [3H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [3H]PBR28, although all samples showed [3H]PK11195 binding. There was a marked reduction in the affinity of [3H]PBR28 for TSPO in samples with no visible [3H]PBR28 autoradiographic signal (Ki=188±15.6 nmol/L), relative to those showing normal signal (Ki=3.4±0.5 nmol/L, P<0.001). Of this latter group, [3H]PBR28 bound with a two-site fit in 40% of cases, with affinities (Ki) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in Kd or Bmax for [3H]PK11195 in samples showing no [3H]PBR28 autoradiographic signal relative to those showing normal [3H]PBR28 autoradiographic signal. [3H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [11C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.
AbstractList [(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [(11)C]PK11195, another TSPO radioligand. We measured the specific binding signals with [(3)H]PK11195 and [(3)H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [(3)H]PBR28, although all samples showed [(3)H]PK11195 binding. There was a marked reduction in the affinity of [(3)H]PBR28 for TSPO in samples with no visible [(3)H]PBR28 autoradiographic signal (K(i)=188+/-15.6 nmol/L), relative to those showing normal signal (K(i)=3.4+/-0.5 nmol/L, P<0.001). Of this latter group, [(3)H]PBR28 bound with a two-site fit in 40% of cases, with affinities (K(i)) of 4.0+/-2.4 nmol/L (high-affinity site) and 313+/-77 nmol/L (low-affinity site). There was no difference in K(d) or B(max) for [(3)H]PK11195 in samples showing no [(3)H]PBR28 autoradiographic signal relative to those showing normal [(3)H]PBR28 autoradiographic signal. [(3)H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [(11)C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.
[ super(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [ super(11)C]PK11195, another TSPO radioligand. We measured the specific binding signals with [ super(3)H]PK11195 and [ super(3)H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [ super(3)H]PBR28, although all samples showed [ super(3)H]PK11195 binding. There was a marked reduction in the affinity of [ super(3)H]PBR28 for TSPO in samples with no visible [ super(3)H]PBR28 autoradiographic signal (K sub(i)=188 plus or minus 15.6nmol/L), relative to those showing normal signal (K sub(i)=3.4 plus or minus 0.5nmol/L, P<0.001). Of this latter group, [ super(3)H]PBR28 bound with a two-site fit in 40% of cases, with affinities (K sub(i)) of 4.0 plus or minus 2.4nmol/L (high-affinity site) and 313 plus or minus 77nmol/L (low-affinity site). There was no difference in K sub(d) or B sub(max) for [ super(3)H]PK11195 in samples showing no [ super(3)H]PBR28 autoradiographic signal relative to those showing normal [ super(3)H]PBR28 autoradiographic signal. [ super(3)H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [ super(11)C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.
[11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [11C]PK11195, another TSPO radioligand. We measured the specific binding signals with [3H]PK11195 and [3H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [3H]PBR28, although all samples showed [3H]PK11195 binding. There was a marked reduction in the affinity of [3H]PBR28 for TSPO in samples with no visible [3H]PBR28 autoradiographic signal (Ki=188±15.6 nmol/L), relative to those showing normal signal (Ki=3.4±0.5 nmol/L, P<0.001). Of this latter group, [3H]PBR28 bound with a two-site fit in 40% of cases, with affinities (Ki) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in Kd or Bmax for [3H]PK11195 in samples showing no [3H]PBR28 autoradiographic signal relative to those showing normal [3H]PBR28 autoradiographic signal. [3H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [11C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.
[ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [ 11 C]PK11195, another TSPO radioligand. We measured the specific binding signals with [ 3 H]PK11195 and [ 3 H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [ 3 H]PBR28, although all samples showed [ 3 H]PK11195 binding. There was a marked reduction in the affinity of [ 3 H]PBR28 for TSPO in samples with no visible [ 3 H]PBR28 autoradiographic signal ( K i =188±15.6 nmol/L), relative to those showing normal signal ( K i =3.4±0.5 nmol/L, P <0.001). Of this latter group, [ 3 H]PBR28 bound with a two-site fit in 40% of cases, with affinities ( K i ) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in K d or B max for [ 3 H]PK11195 in samples showing no [ 3 H]PBR28 autoradiographic signal relative to those showing normal [ 3 H]PBR28 autoradiographic signal. [ 3 H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [ 11 C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.
[ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers. This phenomenon has not been reported for [ 11 C]PK11195, another TSPO radioligand. We measured the specific binding signals with [ 3 H]PK11195 and [ 3 H]PBR28 in brain tissue from 22 donors. Overall, 23% of the samples did not generate a visually detectable specific autoradiographic signal with [ 3 H]PBR28, although all samples showed [ 3 H]PK11195 binding. There was a marked reduction in the affinity of [ 3 H]PBR28 for TSPO in samples with no visible [ 3 H]PBR28 autoradiographic signal ( K i =188±15.6 nmol/L), relative to those showing normal signal ( K i =3.4±0.5 nmol/L, P<0.001). Of this latter group, [ 3 H]PBR28 bound with a two-site fit in 40% of cases, with affinities ( K i ) of 4.0±2.4 nmol/L (high-affinity site) and 313±77 nmol/L (low-affinity site). There was no difference in K d or B max for [ 3 H]PK11195 in samples showing no [ 3 H]PBR28 autoradiographic signal relative to those showing normal [ 3 H]PBR28 autoradiographic signal. [ 3 H]PK11195 bound with a single site for all samples. The existence of three different binding patterns with PBR28 (high-affinity binding (46%), low-affinity binding (23%), and two-site binding (31%)) suggests that a reduction in [ 11 C]PBR28 binding may not be interpreted simply as a reduction in TSPO density. The functional significance of differences in binding characteristics warrants further investigation.
Author Rabiner, Eugenii A
Matthews, Paul M
Owen, David R
Gunn, Roger N
Parker, Christine A
Tang, Sac-Pham
Bergstrom, Mats
Reynolds, Richard
Bennacef, Idriss
Wilkins, Martin R
Wells, Lisa A
Howell, Owain W
Author_xml – sequence: 1
  givenname: David R
  surname: Owen
  fullname: Owen, David R
  email: d.owen@imperial.ac.uk
– sequence: 2
  givenname: Owain W
  surname: Howell
  fullname: Howell, Owain W
– sequence: 3
  givenname: Sac-Pham
  surname: Tang
  fullname: Tang, Sac-Pham
– sequence: 4
  givenname: Lisa A
  surname: Wells
  fullname: Wells, Lisa A
– sequence: 5
  givenname: Idriss
  surname: Bennacef
  fullname: Bennacef, Idriss
– sequence: 6
  givenname: Mats
  surname: Bergstrom
  fullname: Bergstrom, Mats
– sequence: 7
  givenname: Roger N
  surname: Gunn
  fullname: Gunn, Roger N
– sequence: 8
  givenname: Eugenii A
  surname: Rabiner
  fullname: Rabiner, Eugenii A
– sequence: 9
  givenname: Martin R
  surname: Wilkins
  fullname: Wilkins, Martin R
– sequence: 10
  givenname: Richard
  surname: Reynolds
  fullname: Reynolds, Richard
– sequence: 11
  givenname: Paul M
  surname: Matthews
  fullname: Matthews, Paul M
– sequence: 12
  givenname: Christine A
  surname: Parker
  fullname: Parker, Christine A
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23293111$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20424634$$D View this record in MEDLINE/PubMed
BookMark eNp1ku1rFDEQxoNU7LX60a-yCCIIW_O22V0_CF6pXqHYw54giITZbHLm2E3OZLfF_97cS60W_ZIQ5jfPzDOZI3TgvNMIPSX4hGBWvV6pxvQnFKe3YA_QhBRFnZeYiAM0wbQkuSirL4foKMYVxrhiRfEIHVLMKReMT5BZ3Phsal1r3TK7soOOmfEh-8pm3-bTT7TKrMtmYw8umwaw7k123q87q2Cw3u3QxdX8MpufLVIElhsVb7KPegzeOtNB32_Rx-ihgS7qJ_v7GH1-f7Y4neUXlx_OT99d5IqXfMhbApgzkk5TAyWMl9QUhGtNeV1hRUXDsSCg24oI3bRlC8liUbcaGkEV0ewYvd3prsem163SbgjQyXWwPYSf0oOVf0ec_S6X_lrSmtdU4CTwci8Q_I9Rx0H2NirddeC0H6NM1RgRlJBEPr9HrvwYXHInS15zTKuSJ-jZn_38buT2AxLwYg9AVNCZAE7ZeMcxmuptq7Edp4KPMWgjlR22o002bCcJlpt1kNt1kJt1kIKlrPxe1q3w__hXOz7CUt_5-Tf8Czoww5M
CODEN JCBMDN
CitedBy_id crossref_primary_10_1038_jcbfm_2014_46
crossref_primary_10_1016_j_bmcl_2014_01_080
crossref_primary_10_1111_bcp_15392
crossref_primary_10_1038_jcbfm_2011_55
crossref_primary_10_1007_s12017_016_8385_y
crossref_primary_10_1080_13543776_2022_2032649
crossref_primary_10_1007_s11307_015_0877_x
crossref_primary_10_1021_acsomega_1c01678
crossref_primary_10_2967_jnumed_116_178996
crossref_primary_10_3390_ijms20133161
crossref_primary_10_1039_c3md00249g
crossref_primary_10_1093_brain_awad322
crossref_primary_10_1002_syn_21970
crossref_primary_10_1007_s12149_015_0948_8
crossref_primary_10_1021_acs_jmedchem_1c01562
crossref_primary_10_2967_jnumed_117_203109
crossref_primary_10_1146_annurev_med_041709_133809
crossref_primary_10_1021_acs_molpharmaceut_2c00157
crossref_primary_10_1021_acschemneuro_6b00056
crossref_primary_10_1053_j_semnuclmed_2024_09_007
crossref_primary_10_2967_jnumed_120_243717
crossref_primary_10_1016_j_cct_2023_107087
crossref_primary_10_1007_s00259_011_1864_3
crossref_primary_10_1007_s00259_017_3799_9
crossref_primary_10_1111_ejn_14392
crossref_primary_10_1007_s11307_012_0589_4
crossref_primary_10_3390_molecules26051250
crossref_primary_10_1007_s40336_015_0141_z
crossref_primary_10_2967_jnumed_111_091694
crossref_primary_10_1007_s00259_021_05617_4
crossref_primary_10_1111_jnc_14615
crossref_primary_10_1177_0271678X16653615
crossref_primary_10_2967_jnumed_111_094565
crossref_primary_10_1007_s11481_010_9243_6
crossref_primary_10_1007_s00259_010_1622_y
crossref_primary_10_1002_ana_25251
crossref_primary_10_1186_ar4509
crossref_primary_10_1038_jcbfm_2012_46
crossref_primary_10_3390_ijms242417419
crossref_primary_10_1016_j_neuroimage_2013_09_021
crossref_primary_10_1042_BCJ20170648
crossref_primary_10_1177_0271678X19858003
crossref_primary_10_1016_j_jalz_2019_02_004
crossref_primary_10_1021_jm5007947
crossref_primary_10_1039_C6MD00523C
crossref_primary_10_2967_jnumed_117_195396
crossref_primary_10_3233_JAD_179929
crossref_primary_10_1007_s00249_020_01487_0
crossref_primary_10_12688_f1000research_11603_1
crossref_primary_10_2967_jnumed_110_079459
crossref_primary_10_1109_TRPMS_2018_2871760
crossref_primary_10_1186_s12974_015_0236_5
crossref_primary_10_2967_jnumed_113_135129
crossref_primary_10_3390_molecules27092780
crossref_primary_10_1002_acn3_50837
crossref_primary_10_3390_jcm12010116
crossref_primary_10_3390_life11060484
crossref_primary_10_1007_s12264_017_0202_6
crossref_primary_10_2147_NDT_S334027
crossref_primary_10_2967_jnumed_117_202200
crossref_primary_10_1016_j_cpet_2020_12_003
crossref_primary_10_1021_jm101230g
crossref_primary_10_1177_0271678X17710182
crossref_primary_10_1007_s11481_017_9765_2
crossref_primary_10_3390_cells12172128
crossref_primary_10_1021_jm4001874
crossref_primary_10_3390_ijms22020951
crossref_primary_10_1038_jcbfm_2011_147
crossref_primary_10_1161_STROKEAHA_110_598821
crossref_primary_10_1016_j_yexcr_2016_12_005
crossref_primary_10_1093_brain_awv184
crossref_primary_10_1002_syn_21681
crossref_primary_10_1177_0269881112443746
crossref_primary_10_1016_j_ejmech_2015_02_004
crossref_primary_10_1093_brain_awv066
crossref_primary_10_1021_acschemneuro_0c00362
crossref_primary_10_1021_acs_jmedchem_3c01716
crossref_primary_10_2967_jnumed_115_156083
crossref_primary_10_3389_fpsyt_2020_00362
crossref_primary_10_1016_j_ejmech_2018_09_069
crossref_primary_10_1016_j_jfluchem_2011_03_020
crossref_primary_10_1186_s12974_016_0778_1
crossref_primary_10_2967_jnumed_112_118885
crossref_primary_10_1177_1352458510390070
crossref_primary_10_1007_s00259_016_3587_y
crossref_primary_10_1212_NXI_0000000000001144
crossref_primary_10_1586_14737175_2014_896201
crossref_primary_10_1016_S2215_0366_20_30255_8
crossref_primary_10_1007_s00259_015_3021_x
crossref_primary_10_3389_fnins_2020_00871
crossref_primary_10_1016_j_ejrad_2020_109182
crossref_primary_10_1517_17460441_2015_1032240
crossref_primary_10_3389_fneur_2018_01033
crossref_primary_10_1039_D1MD00035G
crossref_primary_10_1021_cn500138n
crossref_primary_10_1111_jnc_15615
crossref_primary_10_1007_s11307_019_01323_8
crossref_primary_10_1038_nrd3295
crossref_primary_10_1007_s00259_015_3043_4
crossref_primary_10_1177_0271678X17748786
crossref_primary_10_1186_1742_2094_11_120
crossref_primary_10_1186_s13195_019_0491_2
crossref_primary_10_1176_appi_ajp_2016_16020171
crossref_primary_10_1007_s00259_021_05495_w
crossref_primary_10_1016_j_bbamem_2013_12_013
crossref_primary_10_1016_j_neuroimage_2011_10_060
crossref_primary_10_1016_j_bbi_2020_01_020
crossref_primary_10_1093_braincomms_fcac019
crossref_primary_10_2967_jnumed_119_231985
crossref_primary_10_1007_s00259_025_07109_1
crossref_primary_10_3389_fimmu_2019_02724
crossref_primary_10_1038_nrneurol_2017_129
crossref_primary_10_1007_s00259_014_2955_8
crossref_primary_10_1007_s11910_017_0733_2
crossref_primary_10_2967_jnumed_113_121020
crossref_primary_10_1093_brain_awab336
crossref_primary_10_1186_s13550_014_0020_z
crossref_primary_10_1016_j_nucmedbio_2019_01_003
crossref_primary_10_1016_j_nbd_2018_06_004
crossref_primary_10_1007_s40336_015_0146_7
crossref_primary_10_2967_jnumed_119_241059
crossref_primary_10_1039_C4OB01933D
crossref_primary_10_2967_jnumed_115_165019
crossref_primary_10_1002_stem_2253
crossref_primary_10_1371_journal_pone_0185767
crossref_primary_10_3389_fnins_2022_806876
crossref_primary_10_2174_0929867329666220329204054
crossref_primary_10_1016_j_bbi_2018_09_018
crossref_primary_10_1016_j_seizure_2016_10_023
crossref_primary_10_1002_jlcr_3199
crossref_primary_10_1007_s00702_017_1731_x
crossref_primary_10_1007_s13244_011_0128_x
crossref_primary_10_1016_j_jalz_2014_08_105
crossref_primary_10_3390_ph16020279
crossref_primary_10_3389_fnimg_2023_1142463
crossref_primary_10_1053_j_semnuclmed_2015_09_001
crossref_primary_10_1007_s00259_019_04462_w
crossref_primary_10_1007_s00259_021_05248_9
crossref_primary_10_1038_jcbfm_2012_131
crossref_primary_10_1002_glia_22357
crossref_primary_10_1007_s11910_019_0934_y
crossref_primary_10_1097_SHK_0000000000001546
crossref_primary_10_1016_j_neuroimage_2011_12_078
crossref_primary_10_1177_0271678X17699223
crossref_primary_10_1007_s00259_011_2041_4
crossref_primary_10_1002_mds_26907
crossref_primary_10_1007_s00259_018_3974_7
crossref_primary_10_1002_syn_21765
crossref_primary_10_1038_s41596_021_00584_4
crossref_primary_10_3233_JAD_190127
crossref_primary_10_2967_jnumed_110_086629
crossref_primary_10_2214_AJR_18_19822
crossref_primary_10_1016_j_neuroimage_2011_02_020
crossref_primary_10_1038_mp_2015_1
Cites_doi 10.1016/j.nbd.2005.08.002
10.1016/j.neuroimage.2009.11.056
10.1016/j.neuroimage.2007.11.011
10.1016/j.tips.2006.06.005
10.1021/jm0707370
10.1016/0361-9230(87)90033-5
10.1002/syn.20394
10.1021/bi010431+
10.1016/0006-8993(90)90973-F
10.1210/endo.135.4.7925120
10.1007/s007020070090
10.1111/j.1471-4159.1989.tb07361.x
10.1016/j.nbd.2008.08.001
10.1016/0140-6736(92)90576-O
10.1016/0006-2952(89)90594-7
10.1016/S0014-2999(97)01395-2
10.1097/NEN.0b013e318188b204
10.1111/j.1471-4159.1987.tb01007.x
10.1111/j.1471-4159.1990.tb05794.x
10.1016/j.nucmedbio.2007.12.009
10.1006/bbrc.2001.4975
10.1016/j.bmc.2003.10.050
10.1093/brain/123.11.2321
10.1210/endo.137.12.8940407
10.1023/A:1005933226966
10.1093/brain/124.10.2014
10.1074/jbc.272.44.28102
10.1021/jm7014556
10.1111/j.1600-0773.1988.tb00922.x
10.1016/j.neuroimage.2007.09.063
ContentType Journal Article
Copyright 2010 ISCBFM
2015 INIST-CNRS
Copyright Nature Publishing Group Sep 2010
Copyright © 2010 International Society for Cerebral Blood Flow & Metabolism, Inc. 2010 International Society for Cerebral Blood Flow & Metabolism, Inc.
Copyright_xml – notice: 2010 ISCBFM
– notice: 2015 INIST-CNRS
– notice: Copyright Nature Publishing Group Sep 2010
– notice: Copyright © 2010 International Society for Cerebral Blood Flow & Metabolism, Inc. 2010 International Society for Cerebral Blood Flow & Metabolism, Inc.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7TK
5PM
DOI 10.1038/jcbfm.2010.63
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Neurosciences Abstracts
DatabaseTitleList ProQuest Central Student
Neurosciences Abstracts


CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
DocumentTitleAlternate [3H]PBR28 binding in the human brain
EISSN 1559-7016
EndPage 1618
ExternalDocumentID PMC2949260
2127460911
20424634
23293111
10_1038_jcbfm_2010_63
10.1038_jcbfm.2010.63
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: G0900897
– fundername: Wellcome Trust
– fundername: Medical Research Council
  grantid: G9901399
– fundername: Medical Research Council
  grantid: G0700356
GroupedDBID ---
-Q-
-TM
.55
.GJ
0R~
29K
2WC
36B
39C
3O-
4.4
53G
54M
5GY
5RE
5VS
70F
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AABMB
AACKU
AACMV
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJPV
AAKGS
AANSI
AAPEO
AAQGT
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAVDI
AAXOT
AAYTG
AAZBJ
ABAWP
ABAWZ
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHKI
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQNX
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEBD
ADEIA
ADMPF
ADNON
ADRRZ
ADTBJ
ADUKL
ADVBO
ADZZY
AECGH
AENEX
AEPTA
AEQLS
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFFNX
AFFZS
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AFVCE
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AHDMH
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BBNVY
BBRGL
BDDNI
BENPR
BHPHI
BKIIM
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
C45
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
D-I
DC-
DC.
DIK
DOPDO
DV7
E3Z
EBS
EE.
EJD
EMOBN
F5P
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HCIFZ
HMCUK
HYE
HZ~
J8X
JSO
K.F
KQ8
LK8
M1P
M7P
O9-
OK1
OVD
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
RNS
RNTTT
ROL
RPM
SASJQ
SAUOL
SCNPE
SFC
SHG
SPQ
SPV
TEORI
TR2
UKHRP
W2D
X7M
YFH
YOC
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ZXP
AAYXX
AJGYC
CITATION
AAEJI
AAPII
AJVBE
IQODW
PJZUB
PPXIY
PQGLB
ALTZF
CGR
CUY
CVF
ECM
EIF
M4V
NPM
PMFND
3V.
7XB
88A
8FK
AJHME
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7TK
5PM
ID FETCH-LOGICAL-c474t-d1a04311a0f9a213472f514ee24980c26b4061aed816ebd7da02759deab62c1e3
IEDL.DBID 7X7
ISSN 0271-678X
IngestDate Thu Aug 21 18:16:13 EDT 2025
Mon Jul 21 11:03:14 EDT 2025
Wed Aug 13 09:06:39 EDT 2025
Sat May 31 02:08:41 EDT 2025
Mon Jul 21 09:15:45 EDT 2025
Thu Apr 24 23:07:39 EDT 2025
Tue Jul 01 05:27:38 EDT 2025
Tue Jun 17 22:36:26 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords [3H]PBR28
PBR
radioligand binding
TSPO
[3H]PK11195
Human
Nervous system diseases
H]PBR28
Cerebral disorder
Encephalon
Central nervous system disease
H]PK11195
[
Positron emission tomography
Cerebrovascular disease
Language English
License https://journals.sagepub.com/page/policies/text-and-data-mining-license
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-d1a04311a0f9a213472f514ee24980c26b4061aed816ebd7da02759deab62c1e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.63
PMID 20424634
PQID 749402874
PQPubID 31524
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2949260
proquest_miscellaneous_759316211
proquest_journals_749402874
pubmed_primary_20424634
pascalfrancis_primary_23293111
crossref_citationtrail_10_1038_jcbfm_2010_63
crossref_primary_10_1038_jcbfm_2010_63
sage_journals_10_1038_jcbfm_2010_63
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-09-01
PublicationDateYYYYMMDD 2010-09-01
PublicationDate_xml – month: 09
  year: 2010
  text: 2010-09-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: New York, NY
– name: United States
– name: London
PublicationTitle Journal of cerebral blood flow and metabolism
PublicationTitleAlternate J Cereb Blood Flow Metab
PublicationYear 2010
Publisher SAGE Publications
Nature Publishing Group
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Nature Publishing Group
– name: Sage Publications Ltd
References Imaizumi, Briard, Zoghbi, Gourley, Hong, Fujimura, Pike, Innis, Fujita 2008; 39
Kreisl, Fujita, Fujimura, Kimura, Jenko, Kannan, Hong, Morse, Zoghbi, Gladding, Jacobson, Oh, Pike, Innis 2010; 49
Banati, Newcombe, Gunn, Cagnin, Turkheimer, Heppner, Price, Wegner, Giovannoni, Miller, Perkin, Smith, Hewson, Bydder, Kreutzberg, Jones, Cuzner, Myers 2000; 123
Boujrad, Vidic, Papadopoulos 1996; 137
Hall, Wedel, Halldin, Kopp, Farde 1990; 55
Joseph-Liauzun, Farges, Delmas, Ferrara, Loison 1997; 272
Gerhard, Pavese, Hotton, Turkheimer, Es, Hammers, Eggert, Oertel, Banati, Brooks 2006; 21
Miyazawa, Hamel, Diksic 1998; 38
Cagnin, Myers, Gunn, Lawrence, Stevens, Kreutzberg, Jones, Banati 2001; 124
Fookes, Pham, Mattner, Greguric, Loc'h, Liu, Berghofer, Shepherd, Gregoire, Katsifis 2008; 51
Boujrad, Gaillard, Garnier, Papadopoulos 1994; 135
Wilson, Garcia, Parkes, McCormick, Stephenson, Houle, Vasdev 2008; 35
Broaddus, Bennett 1990; 518
Doble, Malgouris, Daniel, Daniel, Imbault, Basbaum, Uzan, Gueremy, Le 1987; 18
Awad, Gavish 1987; 49
Rao, Butterworth 1997; 340
Awad, Gavish 1989; 38
Papadopoulos, Baraldi, Guilarte, Knudsen, Lacapere, Lindemann, Norenberg, Nutt, Weizman, Zhang, Gavish 2006; 27
Hall, Wedel, Sallemark 1988; 63
Briard, Zoghbi, Imaizumi, Gourley, Shetty, Hong, Cropley, Fujita, Innis, Pike 2008; 51
Lacapere, Delavoie, Li, Peranzi, Maccario, Papadopoulos, Vidic 2001; 284
Eshleman, Murray 1989; 53
Venneti, Wang, Nguyen, Wiley 2008; 67
Edison, Archer, Gerhard, Hinz, Pavese, Turkheimer, Hammers, Tai, Fox, Kennedy, Rossor, Brooks 2008; 32
Fujita, Imaizumi, Zoghbi, Fujimura, Farris, Suhara, Hong, Pike, Innis 2008; 40
Imaizumi, Briard, Zoghbi, Gourley, Hong, Musachio, Gladding, Pike, Innis, Fujita 2007; 61
Golani, Weizman, Leschiner, Spanier, Eckstein, Limor, Yanai, Maaser, Scherubl, Weisinger, Gavish 2001; 40
Kurumaji, Nomoto, Yoshikawa, Okubo, Toru 2000; 107
Okubo, Yoshikawa, Chaki, Okuyama, Nakazato 2004; 12
Ramsay, Weiller, Myers, Cremer, Luthra, Lammertsma, Frackowiak 1992; 339
bibr18-jcbfm.2010.63
bibr26-jcbfm.2010.63
bibr8-jcbfm.2010.63
bibr13-jcbfm.2010.63
bibr21-jcbfm.2010.63
bibr29-jcbfm.2010.63
bibr15-jcbfm.2010.63
bibr23-jcbfm.2010.63
bibr6-jcbfm.2010.63
bibr2-jcbfm.2010.63
bibr19-jcbfm.2010.63
bibr10-jcbfm.2010.63
bibr25-jcbfm.2010.63
bibr4-jcbfm.2010.63
bibr12-jcbfm.2010.63
bibr9-jcbfm.2010.63
bibr17-jcbfm.2010.63
bibr27-jcbfm.2010.63
bibr20-jcbfm.2010.63
bibr14-jcbfm.2010.63
bibr1-jcbfm.2010.63
bibr28-jcbfm.2010.63
bibr7-jcbfm.2010.63
bibr16-jcbfm.2010.63
bibr22-jcbfm.2010.63
bibr24-jcbfm.2010.63
bibr11-jcbfm.2010.63
bibr5-jcbfm.2010.63
bibr3-jcbfm.2010.63
bibr30-jcbfm.2010.63
References_xml – volume: 38
  start-page: 3843
  year: 1989
  end-page: 9
  article-title: Species differences and heterogeneity of solubilized peripheral-type benzodiazepine binding sites
  publication-title: Biochem Pharmacol
– volume: 32
  start-page: 412
  year: 2008
  end-page: 9
  article-title: Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
  publication-title: Neurobiol Dis
– volume: 61
  start-page: 595
  year: 2007
  end-page: 605
  article-title: Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain
  publication-title: Synapse
– volume: 49
  start-page: 2924
  year: 2010
  end-page: 32
  article-title: Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker
  publication-title: Neuroimage
– volume: 340
  start-page: 89
  year: 1997
  end-page: 99
  article-title: Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5–4864 in human brain
  publication-title: Eur J Pharmacol
– volume: 38
  start-page: 19
  year: 1998
  end-page: 26
  article-title: Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods
  publication-title: J Neurooncol
– volume: 39
  start-page: 1289
  year: 2008
  end-page: 98
  article-title: Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors
  publication-title: Neuroimage
– volume: 518
  start-page: 199
  year: 1990
  end-page: 208
  article-title: Peripheral-type benzodiazepine receptors in human glioblastomas: pharmacologic characterization and photoaffinity labeling of ligand recognition site
  publication-title: Brain Res
– volume: 51
  start-page: 17
  year: 2008
  end-page: 30
  article-title: Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors
  publication-title: in vivo. J Med Chem
– volume: 55
  start-page: 2048
  year: 1990
  end-page: 57
  article-title: Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes
  publication-title: J Neurochem
– volume: 137
  start-page: 5727
  year: 1996
  end-page: 30
  article-title: Acute action of choriogonadotropin on Leydig tumor cells: changes in the topography of the mitochondrial peripheral-type benzodiazepine receptor
  publication-title: Endocrinology
– volume: 40
  start-page: 43
  year: 2008
  end-page: 52
  article-title: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation
  publication-title: Neuroimage
– volume: 135
  start-page: 1576
  year: 1994
  end-page: 83
  article-title: Acute action of choriogonadotropin on Leydig tumor cells: induction of a higher affinity benzodiazepine-binding site related to steroid biosynthesis
  publication-title: Endocrinology
– volume: 27
  start-page: 402
  year: 2006
  end-page: 9
  article-title: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function
  publication-title: Trends Pharmacol Sci
– volume: 67
  start-page: 1001
  year: 2008
  end-page: 10
  article-title: The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders
  publication-title: J Neuropathol Exp Neurol
– volume: 272
  start-page: 28102
  year: 1997
  end-page: 6
  article-title: The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier
  publication-title: J Biol Chem
– volume: 53
  start-page: 494
  year: 1989
  end-page: 502
  article-title: Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5–4864 in trout and mouse brain membranes
  publication-title: J Neurochem
– volume: 40
  start-page: 10213
  year: 2001
  end-page: 22
  article-title: Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction
  publication-title: Biochemistry
– volume: 107
  start-page: 491
  year: 2000
  end-page: 500
  article-title: An association study between two missense variations of the benzodiazepine receptor (peripheral) gene and schizophrenia in a Japanese sample
  publication-title: J Neural Transm
– volume: 123
  start-page: 2321
  issue: Part 11
  year: 2000
  end-page: 37
  article-title: The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity
  publication-title: Brain
– volume: 35
  start-page: 305
  year: 2008
  end-page: 14
  article-title: Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors
  publication-title: Nucl Med Biol
– volume: 284
  start-page: 536
  year: 2001
  end-page: 41
  article-title: Structural and functional study of reconstituted peripheral benzodiazepine receptor
  publication-title: Biochem Biophys Res Commun
– volume: 49
  start-page: 1407
  year: 1987
  end-page: 14
  article-title: Binding of [3H]Ro 5–4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites
  publication-title: J Neurochem
– volume: 124
  start-page: 2014
  issue: Part 10
  year: 2001
  end-page: 27
  article-title: In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion
  publication-title: Brain
– volume: 21
  start-page: 404
  year: 2006
  end-page: 12
  article-title: In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
  publication-title: Neurobiol Dis
– volume: 51
  start-page: 3700
  year: 2008
  end-page: 12
  article-title: Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo [1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography
  publication-title: J Med Chem
– volume: 339
  start-page: 1054
  year: 1992
  end-page: 5
  article-title: Monitoring by PET of macrophage accumulation in brain after ischaemic stroke
  publication-title: Lancet
– volume: 63
  start-page: 118
  year: 1988
  end-page: 21
  article-title: Effects of temperature on the in vitro binding of 3H-raclopride to rat striatal dopamine-D2 receptors
  publication-title: Pharmacol Toxicol
– volume: 12
  start-page: 423
  year: 2004
  end-page: 38
  article-title: Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands
  publication-title: Bioorg Med Chem
– volume: 18
  start-page: 49
  year: 1987
  end-page: 61
  article-title: Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution
  publication-title: Brain Res Bull
– ident: bibr14-jcbfm.2010.63
  doi: 10.1016/j.nbd.2005.08.002
– ident: bibr21-jcbfm.2010.63
  doi: 10.1016/j.neuroimage.2009.11.056
– ident: bibr13-jcbfm.2010.63
  doi: 10.1016/j.neuroimage.2007.11.011
– ident: bibr26-jcbfm.2010.63
  doi: 10.1016/j.tips.2006.06.005
– ident: bibr6-jcbfm.2010.63
  doi: 10.1021/jm0707370
– ident: bibr9-jcbfm.2010.63
  doi: 10.1016/0361-9230(87)90033-5
– ident: bibr19-jcbfm.2010.63
  doi: 10.1002/syn.20394
– ident: bibr15-jcbfm.2010.63
  doi: 10.1021/bi010431+
– ident: bibr7-jcbfm.2010.63
  doi: 10.1016/0006-8993(90)90973-F
– ident: bibr4-jcbfm.2010.63
  doi: 10.1210/endo.135.4.7925120
– ident: bibr22-jcbfm.2010.63
  doi: 10.1007/s007020070090
– ident: bibr11-jcbfm.2010.63
  doi: 10.1111/j.1471-4159.1989.tb07361.x
– ident: bibr10-jcbfm.2010.63
  doi: 10.1016/j.nbd.2008.08.001
– ident: bibr27-jcbfm.2010.63
  doi: 10.1016/0140-6736(92)90576-O
– ident: bibr2-jcbfm.2010.63
  doi: 10.1016/0006-2952(89)90594-7
– ident: bibr28-jcbfm.2010.63
  doi: 10.1016/S0014-2999(97)01395-2
– ident: bibr29-jcbfm.2010.63
  doi: 10.1097/NEN.0b013e318188b204
– ident: bibr1-jcbfm.2010.63
  doi: 10.1111/j.1471-4159.1987.tb01007.x
– ident: bibr16-jcbfm.2010.63
  doi: 10.1111/j.1471-4159.1990.tb05794.x
– ident: bibr30-jcbfm.2010.63
  doi: 10.1016/j.nucmedbio.2007.12.009
– ident: bibr23-jcbfm.2010.63
  doi: 10.1006/bbrc.2001.4975
– ident: bibr25-jcbfm.2010.63
  doi: 10.1016/j.bmc.2003.10.050
– ident: bibr3-jcbfm.2010.63
  doi: 10.1093/brain/123.11.2321
– ident: bibr5-jcbfm.2010.63
  doi: 10.1210/endo.137.12.8940407
– ident: bibr24-jcbfm.2010.63
  doi: 10.1023/A:1005933226966
– ident: bibr8-jcbfm.2010.63
  doi: 10.1093/brain/124.10.2014
– ident: bibr20-jcbfm.2010.63
  doi: 10.1074/jbc.272.44.28102
– ident: bibr12-jcbfm.2010.63
  doi: 10.1021/jm7014556
– ident: bibr17-jcbfm.2010.63
  doi: 10.1111/j.1600-0773.1988.tb00922.x
– ident: bibr18-jcbfm.2010.63
  doi: 10.1016/j.neuroimage.2007.09.063
SSID ssj0008355
Score 2.4204035
Snippet [11C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers....
[ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers....
[(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers....
[ super(11)C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy...
[ 11 C]PBR28, a radioligand targeting the translocator protein (TSPO), does not produce a specific binding signal in approximately 14% of healthy volunteers....
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1608
SubjectTerms Acetamides - metabolism
Adult
Aged
Aged, 80 and over
Autoradiography
Binding Sites
Binding, Competitive - drug effects
Biological and medical sciences
Brain - diagnostic imaging
Brain Chemistry
Carbon Radioisotopes
Female
Humans
Immunohistochemistry
Investigative techniques, diagnostic techniques (general aspects)
Isoquinolines
Male
Medical sciences
Membranes - diagnostic imaging
Membranes - metabolism
Middle Aged
Nerve Tissue Proteins - analysis
Nerve Tissue Proteins - metabolism
Nervous system
Neuritis - diagnostic imaging
Neurology
Original
Positron-Emission Tomography
Pyridines - metabolism
Radioligand Assay
Receptors, GABA - metabolism
Tissue Banks
Ultrasonic investigative techniques
Vascular diseases and vascular malformations of the nervous system
Title Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation
URI https://journals.sagepub.com/doi/full/10.1038/jcbfm.2010.63
https://www.ncbi.nlm.nih.gov/pubmed/20424634
https://www.proquest.com/docview/749402874
https://www.proquest.com/docview/759316211
https://pubmed.ncbi.nlm.nih.gov/PMC2949260
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9RAEB60fVCQoq3WWD0WlD659HaT2yS-SFuuHIL1qFc4EAn7K3hik9O7Uvrfd2aTS3tYfUhedhKy2cnuNztfvgF453BVxWVkwHNlS56UQnOd5oJLi_jZZDo2njb0P5-q0XnyaTqYttycRUurXM2JYaJ2taU98oM0yTHUydLk4_w3p6JRlFxtK2g8hE1SLiOnTqddvEXgIjAYZSo4zsnTVmKzH2cHP60pLxpil4rXlqQnc73At1M2ZS3uw51_0yfvcMDCsnTyFLZaPMkOGwd4Bg98tQ07hxXG0hfXbJ8FhmfYOt-GR8er6m47UE6uamZm4Z8WRp1cMISv7Fs8-j4-OpMZm1Us1O9jhopIfGCzO9TzYDr5Ov7CxsMJtoRKR6wuWVDHRJ9FN2t-iXwO5yfDyfGItzUXuE3SZMmd0CS3g-cy16T2lsoSMZX3GKZlfSuVIQSgvcuE8salTlPeM3deGyWt8PEL2Kjqyr8ERmCk73BGcBjyJVpoN9BC4WGlyYzMI3i_eu2FbQXJqS7GryIkxuOsCKNU0CgVKo5gvzOfN0oc_zLsrY1hZ43gMceuiQj2VoNatF_souj8KwLWteKYUP5EV76-RJMBXq4k3WC38YDbW1MGWcV4cbrmG50BqXivt1SzH0HNW-ak2diP4C150e0D3du3V_999D143JAbiAL3GjaWfy79G8RMS9MLX0YPNo-Gp-OzG_a6FqA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEJ8gPmBijIIfFcFNVJ5saLe9bWtiDCLkkA8vWpJLiKm73W08I-3BHSH8Uf6PzGw_4CL6xkP7srObbWd25zc7szMArzVqVVQjPTcReeGGhS9dGSW-y3PEzyqWgTJ0oL9_IPqH4edhbzgHf9q7MBRW2e6JdqPWVU5n5OtRmKCpE0fhh_GJS0WjyLnaVtCopWLXXJyjxTZ5v_MJ2fuG8-2tdLPvNkUF3DyMwqmrfUn5ZPBdJJLSmUW8QNBgDNohsZdzoUjFSaNjXxilIy3JsZdoI5XguW8CHPcO3MUhPLL1omFn3xGYsRGTPPJd1AHDJqWnF8Trv3JVHNeBZCKYUYH3x3KC3CjqMho34dy_wzWvxZxZNbj9EB40-JVt1AL3COZMuQhLGyXa7scXbI3ZiFJ7VL8IC5ttNbklKNLziqmRvUPD6KdOGMJldhT0vw8-fuUxG5XM1gtkiopWvGOja6HuljT9NvjCBlspttjKSqwqmM3GiWsExbq-gvkYDm-FHU9gvqxK8wwYgR9P4w6k0cQMpS91T_oCn5yrWPHEgbftb8_yJgE61eH4nVlHfBBnlksZcSkTgQNrHfm4zvzxL8LVGR521AhWE_w034HllqlZs0NMsk6eHWBdK_KE_DWyNNUZkvSwu-A0wNNaAq6GJo-1CLBzNCMbHQFlDZ9tKUc_bfZwnlCOSM-BVyRFVxO68due_3fqL2Ghn-7vZXs7B7vLcK8OrKDwuxcwPz09MyuI16Zq1a4SBj9ue1leAi8SUWE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Two+binding+sites+for+%5B+super%283%29H%5DPBR28+in+human+brain%3A+implications+for+TSPO+PET+imaging+of+neuroinflammation&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Owen%2C+David+R&rft.au=Howell%2C+Owain+W&rft.au=Tang%2C+Sac-Pham&rft.au=Wells%2C+Lisa+A&rft.date=2010-09-01&rft.issn=0271-678X&rft.volume=30&rft.issue=9&rft.spage=1608&rft.epage=1618&rft_id=info:doi/10.1038%2Fjcbfm.2010.63&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon